Published July 6, 2020 | Version v1
Project deliverable Open

Report on scope and limitations of in vivo and in vitro non-clinical and computational models for drug milk excretion and breastfed infant exposure; Selection of a panel of at least 10 model compounds for initial evaluation of non-clinical models (D3.1)

  • 1. KUL

Description

This deliverable will reveal the advantages and limitations of the current state-of-the-art, which will serve as a starting point for the development of a non-clinical testing platform to study the transfer of medicines during lactation.

Files

821520_ConcePTION - D3.1 Scope and limitations of in vivo and in vitro non-clinical and computational models for drug milk excretion and breastfed infant exposure.pdf

Additional details

Funding

ConcePTION – Building an ecosystem for better monitoring and communicating of medication safety in pregnancy and breastfeeding: validated and regulatory endorsed workflows for fast, optimised evidence generation 821520
European Commission